Oncternal Therapeutics Inc. buy Oppenheimer Holdings Inc.
Start price
22.03.23
/
50%
€0.60
Target price
22.03.24
€8.34
Performance (%)
-55.62%
End price
23.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by Oppenheimer_Holdings for Oncternal Therapeutics Inc. is performing very badly with a performance of -55.62%. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oncternal Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1,42 % | 8,92 % | 7,31 % | 49,21 % |
| iShares Nasdaq 100 | 3,27 % | 16,28 % | 36,65 % | 97,34 % |
| iShares Nikkei 225® | 1,75 % | 16,24 % | 46,60 % | 64,98 % |
| iShares S&P 500 | 1,45 % | 10,91 % | 27,17 % | 68,77 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $14.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for ONCT provided by MarketBeat
In the thread Trading Oncternal Therapeutics Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten